Inflammatory disease not major risk factors for severe COVID-19, focus on comorbidities urged

FHS
May 3, 2024
10:30 am

Severe coronavirus disease 2019 (COVID-19) outcomes in patients with immune-mediated inflammatory diseases (IMIDs).

Daiichi Sankyo brings Glycotope antibody in-house for $132.5M

Daiichi Sankyo is spending $132.5 million to buy an antibody outright that it had already licensed from Glycotope. The one-off fee “satisfies” all milestone and

January 15, 2025

Is There a Surgical Shortcut to Six-Pack Abs?

Welcome to Culture Clinic, MedPage Today‘s collaboration with Northwell Health to offer a healthcare professional’s take on the latest viral medical topics. Getting defined six-pack

September 12, 2024

More than half the slots on a key vaccine advisory panel are vacant. Where’s HHS?

A critical government advisory committee charged with charting U.S. vaccination policy appears to be atrophying, jeopardizing timely decision-making on how vaccines should be used in

February 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.